Cleared Traditional

K202022 - GMK-SPHERE Tibial inserts FLEX Tibial I...

K202022 is the FDA 510(k) clearance for GMK-SPHERE Tibial inserts FLEX Tibial I... by Medacta International S.A.. It is a Class 2 Orthopedic device (product code JWH) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K202022 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
58d
Days
Class 2
Risk

K202022 is an FDA 510(k) clearance for the GMK-SPHERE Tibial inserts FLEX Tibial Insert CR and Resurfacing Patella made .... Classified as Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (product code JWH), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on September 18, 2020 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medacta International S.A. devices

Submission Details

510(k) Number K202022 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2020
Decision Date September 18, 2020
Days to Decision 58 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 122d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer

All 778
Devices cleared under the same product code (JWH) and FDA review panel - the closest regulatory comparables to K202022.
Freedom(R) - TiNbN Coated Knee
K200912 · Maxx Orthopedics, Inc. · Nov 2020
Mobio Total Knee System
K202429 · B-One Ortho, Corp. · Oct 2020
Klassic Knee System Tibial Inserts, PS-Max
K202740 · Total Joint Orthopedics, Inc. · Oct 2020
EXULT Femoral component trial - Left, EXULT Femoral component trial - Right
K201851 · Corentec Co., Ltd. · Jul 2020
Triathlon Total KneeSystem
K201343 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Jul 2020
TRUMATCH Personalized Solutions
K193540 · DePuy Orthopaedics, Inc. · Jun 2020